Unravelling the brain targets of γ-hydroxybutyric acid
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
γ-Hydroxybutyric acid (GHB) is a naturally occurring γ-aminobutyric acid (GABA) metabolite that has been proposed as a neurotransmitter/neuromodulator that acts via its own receptor (GHBR). Its exogenous administration, however, elicits central nervous system-dependent effects (e.g. memory impairment, increase in sleep stages 3 and 4, dependence, seizures and coma) that are mostly mediated by GABAB receptors. The past few years have seen important developments in our understanding of GHB neurobiology: a putative GHBR has been cloned; a transgenic model of GHB aciduria has been developed; GABAB receptor knockout mice and novel GHB analogs have helped to characterize the vast majority of exogenous GHB actions mediated by GABAB receptors; and some of the cellular mechanisms underlying the dependence/abuse properties of GHB, and its ability to elicit absence seizures and an increase in sleep stages 3 and 4, have been clarified. Nevertheless, the physiological significance of a brain GHB signaling pathway is still unknown, and there is an urgent need for a well-validated functional assay for GHBRs. Moreover, as GHB can also be metabolized to GABA, it remains to be seen whether the many GABAB receptor-mediated actions of GHB are caused by GHB itself acting directly on GABAB receptors or by a GHB-derived GABA pool (or both).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular Mechanisms of the Slow (<1 Hz) Oscillation in Thalamocortical Neurons In Vitro
Hughes, S. W., Cope, D. W., Blethyn, K. L., & Crunelli, V. (2002) · Neuron · doi:10.1016/s0896-6273(02)00623-2 · Cited by 243
Self-citationVan Cauter, E., Plat, L., Scharf, M. B., Leproult, R., Cespedes, S., L'Hermite-Balériaux, M., & Copinschi, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119587 · Cited by 234 · cited 1×
“GHB administered to healthy volunteers [39] and during the treatment of human cataplexy/ narcolepsy [9,10] leads to an increase in stages 3 and 4 of non-REM sleep (which are characterized by a progressive contribution of delta waves in the electroencephalogram [EEG]), an action mirrored by the GHB-elicited induction o…”
BackgroundPharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase
Hogema, B. M., Gupta, M., Senephansiri, H., Burlingame, T. G., Taylor, M., Jakobs, C., Schutgens, R. B. H., Froestl, W., Snead, O. C., Diaz-Arrastia, R., et al. (2001) · Nature Genetics · doi:10.1038/ng727 · Cited by 157 · cited 3×
“Succinic semialdheyde dehydrogenase (SSADH) KO mice (SSADH−/−) [49] have been developed in which a null mutation of this enzyme results in higher GABA and GHB levels in brain, liver, blood and urine, leading to a phenotype similar to the complex spectrum of non-specific neurological symptoms observed in humans sufferi…”
Background
Cited by
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis
Tretter, L., Patocs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.012 · Cited by 539
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. J. (2007) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 534
Regulation of neuronal GABAB receptor functions by subunit composition
Gassmann, M., & Bettler, B. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3249 · Cited by 363
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Walsh, J. K., Hall-Porter, J. M., Griffin, K. S., Dodson, E. R., Forst, E. H., Curry, D. T., Eisenstein, R. D., & Schweitzer, P. K. (2010) · Sleep · doi:10.1093/sleep/33.9.1217 · Cited by 71
Metadata
- Authors
- CRUNELLI, V, EMRI, Z., & LERESCHE, N.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 6
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2012755965
- Cited by
- 118
- References
- 3
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unravelling the brain targets of γ-hydroxybutyric acid. https://app.cochat.ai/papers/10.1016/j.coph.2005.10.001
- The paper
- CRUNELLI, V, EMRI, Z., & LERESCHE, N. (2006). Unravelling the brain targets of γ-hydroxybutyric acid. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2005.10.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.